This resolution expresses congressional support for designating July 15, 2026, as "Glioblastoma Awareness Day" to increase public awareness of this deadly brain cancer. Glioblastoma is the most common and aggressive form of malignant brain tumor, with an estimated 13,000 new diagnoses and 10,000 deaths annually in the United States, and a five-year survival rate of only 7.1 percent. The resolution highlights the urgent need for greater awareness and research funding, noting that despite being identified over a century ago, only five drugs and one medical device have been approved specifically to treat glioblastoma, and survival rates have improved little over the past 30 years. The resolution encourages increased public awareness, honors those affected by the disease, supports collaborative research efforts across government and private sectors, and calls for continued investment in glioblastoma research including through the National Cancer Institute's Glioblastoma Therapeutics Network established in 2020. This is a symbolic resolution with no direct funding or enforcement mechanism, serving primarily to raise awareness and demonstrate congressional support for glioblastoma research and treatment development.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.